Kwong-Yok Tsang

This inventor holds 25 USPTO granted patents and 2 published patent applications, plus 10 CIPO patents and 9 EPO patents, primarily in Immunotherapy Research. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Globeimmune, Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwong-Yok Tsang. Retrieved from https://idiyas.com/inventor/kwong-yok-tsang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 2)

% Patents Active = 88.0

CIPO Patents = 10

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 159(Granted Patents)

Company Filing History:

25 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

MUC1-C Epitopes

Immunotherapeutic Compositions

HPV Agonist Epitopes

Prostate-Specific Antigen

Nucleic Acids

Human Cytotoxic T-Lymphocytes

Peptide Agonists

Cancer Treatment

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325731 - HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use (2025-06-10),

2. 11732017 - HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use (2023-08-22),

3. 11311613 - Development of agonist epitopes of the human papillomavirus (2022-04-26),

4. 11155588 - HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use (2021-10-26),

5. 11065318 - Yeast-MUC1 immunotherapeutic compositions and uses thereof (2021-07-20),

6. 10508141 - Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein (2019-12-17),

7. 10188714 - Yeast-MUC1 immunotherapeutic compositions and uses thereof (2019-01-29),

8. 10138271 - Native and agonist CTL epitopes of the MUC1 tumor antigen (2018-11-27),

9. 10035832 - HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use (2018-07-31),

10. 9533031 - Yeast-MUC1 immunotherapeutic compositions and uses thereof (2017-01-03),

11. 9370559 - Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 (2016-06-21),

12. 9175057 - Immunogenic peptides and methods of use (2015-11-03),

13. 8957192 - Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 (2015-02-17),

14. 8933041 - System for treating and preventing breast cancer (2015-01-13),

15. 8901093 - Custom vectors for treating and preventing pancreatic cancer (2014-12-02),

Title: The Innovative Journey of Kwong-Yok Tsang

Introduction: Kwong-Yok Tsang is a pioneering inventor based in Bethesda, MD, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kwong-Yok Tsang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Tsang has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries. His commitment to pushing the boundaries of technology has earned him recognition as a visionary in the field.

Collaborations: Tsang has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge-sharing. His ability to work across disciplines has led to the development of cutting-edge solutions that address complex challenges.

Conclusion: Kwong-Yok Tsang's relentless pursuit of innovation and his passion for creating a positive impact through technology continue to inspire the next generation of inventors and entrepreneurs. His legacy serves as a testament to the power of creativity and perseverance in driving meaningful change in the world of inventions.

Profile summary based on public USPTO records.